What did we buy for $720 million?

Let's see.....the Sirtris site in Cambridge has been (finally) closed, and one, that's right, one, person from the Sirtris staff in Cambridge moved to UP. Some chemistry has been assigned to persons who already were at UP. All done relatively quietly, and for $720 million after biologists from RTP had told research upper management that the data from Sirtris did not make sense and that GSK should not do the deal.

And the head of research as well as the Chairman of R&D still do not trust or believe the internal scientists, preferring academics who never set foot inside a pharmaceutical research building except to give talks and collect very nice honoraria.

 

Special retirement rights for certain corporate personnel. If scientists knew how lower manhattan really works - they would spend less time talking about bad acquisitions and more time investigating exactly where the 720 million is at this moment as well as all of the corresponding downstream assignments. We know where the 720 M came from ( shareholders & and a buffet of retirement funds ) but do we know where it went?

Its great to be a CEO; even beyond the average person's wildest dreams. The purchase my friends was no mistake.

 

What's your point? Yes, the money went into some others pockets. As a researcher the greed and misinformation provided by biotechs to reap millions is not something I can stop. Instead, what I can do is influence internal decision makers from making such stupid, unproductive, wasted investments. MS, PV, Sir AW did not listen then; will they listen now and into the future...I'm doubtful since they are so arrogent, but all that can be done is to point them out for future possible employees, stockholders....